|
|
![]() |
![]() |
![]() |
![]() |
|
![]() |
|
![]() |
|
![]() |
|
![]() |
![]() |
![]() |
|
![]() |
|||||||||||||||||||||||||||||||||||||||||||||
| 1 | Conditions listed in this trial | ||||
| Malnutrition | |||||
| Critical Illness | |||||
| 2 | More general conditions related to this trial | ||||
| Disease Attributes | |||||
| Nutrition Disorders | |||||
| Pathologic Processes | |||||
| 3 | Interventions listed in this trial | ||||
| Nandrolone (anabolic steroid) | |||||
| 4 | Additional drug interventions recognized in this trial | ||||
| Nandrolone | |||||
| 5 | More general drug interventions related to this trial | ||||
| Anabolic Agents | |||||
| Androgens | |||||
| Hormones | |||||
| Hormones, Hormone Substitutes, and Hormone Antagonists | |||||
| Pharmacologic Actions | |||||
| Physiological Effects of Drugs | |||||
| 6 | Sponsors listed in this trial | ||||
| Lawson Health Research Institute | |||||